SCHEMBL4477038

SCHEMBL4477038

CN(C)c1ccc(-c2ccc3c(NC(=O)c4cccc(C#N)c4)n[nH]c3c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.58
FGFR2 P21802 3/20 0.56
FGFR3 P22607 3/20 0.56
FGFR1 P11362 2/20 0.56
HDAC6 Q9UBN7 11/20 0.53
FLT3 P36888 3/20 0.51
CDC7 O00311 1/20 0.50
DAPK3 O43293 1/20 0.50
ROCK2 O75116 1/20 0.50
PAK4 O96013 1/20 0.50
CDK2 P24941 1/20 0.50
CSNK1A1 P48729 1/20 0.50
CDK8 P49336 1/20 0.50
CLK2 P49760 1/20 0.50
CDK7 P50613 1/20 0.50
CDK9 P50750 1/20 0.50
PRKX P51817 1/20 0.50
CDK5 Q00535 1/20 0.50
DYRK1A Q13627 1/20 0.50
MELK Q14680 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4504522 0.86 FGFR2 (0.56) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4480599 0.86 HDAC6 (0.58) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4488328 0.86 HDAC6 (0.66) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4489464 0.86 FGFR2 (0.55) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4479684 0.85 HDAC6 (0.65) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4491952 0.84 HDAC6 (0.56) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4498018 0.83 FGFR2 (0.53) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4487071 0.82 GSK3B (0.58) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4492315 0.81 FGFR1 (0.78) GSK3BFGFR2FGFR3FGFR1HDAC6
SCHEMBL4502183 0.81 FGFR1 (0.75) GSK3BFGFR2FGFR3FGFR1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed